Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Uterine Cervical Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 5Medulloblastoma 4Neuroblastoma 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Hypopharyngeal Neoplasms 2Ganglioneuroblastoma 2Carcinoma, Transitional Cell 2Brain Neoplasms 2Vaginal Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Teratoma 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1PRETEXT I Hepatoblastoma 1Osteosarcoma 1

Interventions

Cyclophosphamide 3Epirubicin 2Docetaxel 2Carboplatin 2Capecitabine 2Azacitidine 2venetoclax 1tegafur-gimeracil-oteracil 1taxane 1sargramostim 1ruxolitinib 1rucaparib 1pirarubicin 1pertuzumab 1pembrolizumab 1olaparib 1cc-486 1Trastuzumab 1Thalidomide 1Radiotherapy 1Radiation 1Platinum 1Paclitaxel 1Oxaliplatin 1Observation 1Nivolumab 1Monatide (IMS 3015) 1Methotrexate 1Magnetic Resonance Imaging 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Pathologic Complete Response × Platinum × Clear all
NCT04335669 2025-09-12

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Lund University Hospital

Phase 3 Active not recruiting
325 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡